Clinical Trials
Patients who participate in clinical trials are critical in advancing medical science. Blaze thanks the patients, caregivers, and healthcare providers involved in its clinical trials.
Blaze is focused on developing Tumor Paint products and related therapeutics. Our first Tumor Paint product candidate, BLZ-100 (tozuleristide), is being developed for brain cancer surgery. Below is more information on our current clinical trial for BLZ-100.
BLZ-100: Pediatric brain cancer (U.S.)
Title: A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System
Status: Completed